Author:
Nagy Bence,Lamarca Angela,McNamara Mairéad G.,Hubner Richard A.,Valle Juan W.
Publisher
Springer International Publishing
Reference75 articles.
1. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27.
2. Lee J, Ahn S, Cho IK, Lee J, Kim J, Hwang J. Management of recurrent pancreatic cancer after surgical resection: systematic review, evidence mapping, and meta-analysis. BMJ. 2018;8(4):1–9.
3. Mukherjee S, Hurt CN, Bridgewater J, Falk S, Cummins S, Wasan H, et al. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol. 2013;14(4):317–26.
4. American Cancer Society. Cancer facts & figures. Atlanta, GA: American Cancer Society; 2019. p. 2019.
5. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330–8.